https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Ironwood-and-Forest-Announce-FDA-Has-Extended-the-Review-Period-for-Linaclotide-to-September-2012/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- April 23, 2012